Roivant Sciences Ltd (ROIV)

Fixed asset turnover

		Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	US$ in thousands	29,053	124,795	61,280	55,286	23,795
Property, plant and equipment	US$ in thousands	—	—	39,086	25,905	77,028
Fixed asset turnover		—	—	1.57	2.13	0.31

March 31, 2025 calculation

Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $29,053K ÷ $—K
= —

The fixed asset turnover ratio for Roivant Sciences Ltd has shown significant fluctuations over the past few years. In March 31, 2021, the ratio was 0.31, indicating that the company generated $0.31 in sales for every dollar invested in fixed assets. This was a relatively low ratio, suggesting inefficiency in utilizing its fixed assets to generate revenue.

However, by March 31, 2022, there was a substantial improvement in the fixed asset turnover ratio to 2.13, signaling that Roivant Sciences Ltd was able to generate $2.13 in sales for every dollar invested in fixed assets. This significant increase may reflect better utilization and productivity of the company's fixed assets during that period.

In the subsequent years, the fixed asset turnover ratio remained relatively stable but slightly decreased to 1.57 by March 31, 2023. This indicates a slight decline in the efficiency of utilizing fixed assets to generate revenue compared to the previous year.

Notably, the data for March 31, 2024, and March 31, 2025, is unavailable (represented as "—"), making it challenging to assess the company's fixed asset turnover performance for those years.

Overall, the trend in the fixed asset turnover ratio for Roivant Sciences Ltd reflects fluctuations in the efficiency of utilizing fixed assets to generate sales revenue. Further analysis would be required to understand the factors driving these changes and to determine the company's overall performance in capital utilization.